143 related articles for article (PubMed ID: 25311065)
1. Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer.
Yu H; Li H; Qian H; Jiao X; Zhu X; Jiang X; Dai G; Huang J
Med Oncol; 2014 Nov; 31(11):283. PubMed ID: 25311065
[TBL] [Abstract][Full Text] [Related]
2. Elevated miR-301a expression indicates a poor prognosis for breast cancer patients.
Zheng JZ; Huang YN; Yao L; Liu YR; Liu S; Hu X; Liu ZB; Shao ZM
Sci Rep; 2018 Feb; 8(1):2225. PubMed ID: 29396508
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Liu H; Wang G
Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
[TBL] [Abstract][Full Text] [Related]
5. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
Xu XD; He XJ; Tao HQ; Zhang W; Wang YY; Ye ZY; Zhao ZS
J Surg Oncol; 2013 Sep; 108(3):197-202. PubMed ID: 23832550
[TBL] [Abstract][Full Text] [Related]
7. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
8. Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer.
Yin J; Chen D; Luo K; Lu M; Gu Y; Zeng S; Chen X; Song Y; Zhang Z; Zheng G; He Z; Liu H
J Cancer; 2019; 10(24):5964-5974. PubMed ID: 31762806
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
[TBL] [Abstract][Full Text] [Related]
10. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
[TBL] [Abstract][Full Text] [Related]
11. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
[TBL] [Abstract][Full Text] [Related]
12. COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer.
Ouyang M; Wang H; Ma J; Lü W; Li J; Yao C; Chang G; Bi J; Wang S; Wang W
BMC Cancer; 2015 Mar; 15():132. PubMed ID: 25884720
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
14. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers.
Bayoglu IV; Kucukzeybek BB; Kucukzeybek Y; Varol U; Yildiz I; Alacacioglu A; Akyol M; Demir L; Dirican A; Yildiz Y; Salman T; Tarhan MO
Biomed Pharmacother; 2015 Mar; 70():190-5. PubMed ID: 25776500
[TBL] [Abstract][Full Text] [Related]
16. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
17. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
18. miR-301a expression: Diagnostic and prognostic marker for prostate cancer.
Kolluru V; Chandrasekaran B; Tyagi A; Dervishi A; Ankem M; Yan X; Maiying K; Alatassi H; Shaheen SP; C Messer J; Edwards A; Haddad A; Damodaran C
Urol Oncol; 2018 Nov; 36(11):503.e9-503.e15. PubMed ID: 30195463
[TBL] [Abstract][Full Text] [Related]
19. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
20. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer.
Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]